Changes in CArG-binding protein A expression levels following injection(s)of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat
Wj. Rushlow et al., Changes in CArG-binding protein A expression levels following injection(s)of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat, NEUROSCIENC, 98(1), 2000, pp. 69-78
We recently characterized the rat brain homolog of mouse muscle CArG-bindin
g protein A initially identified in C2 myogenic cells and showed an inverse
temporal correlation between increased expression levels of this messenger
RNA, c-fos and zif268 messenger RNA levels following the addition of nerve
growth factor to PC12 cells. In addition, we found an inverse correlation
between c-Fos protein and CArG-binding protein A messenger RNA levels in th
e lateral caudate-putamen of rats treated acutely and chronically with the
D2 receptor antagonist fluphenazine (phenothiozine typical psychotic). To d
etermine whether D1 receptor stimulation is also capable of inducing CArG-b
inding protein A up-regulation, drug naive or dopamine-depleted (i.e. 6-hyd
roxydopamine-lesioned) D1 hypersensitized rats (i.e. rats given repeated da
ily injections of SKF-82958 for 14 days) were acutely injected with the D1
agonist SKF-82958 and examined using a combination of in situ hybridization
for CArG binding protein A and immunocytochemistry for c-Fos. Both acutely
treated animals and dopamine-depleted hypersensitized animals showed incre
ases in CArG-binding protein A. Moderate increases were found in the medial
caudate-putamen and nucleus accumbens core and shall regions following acu
te treatment whereas large increases in CArG-binding protein A expression l
evels were found in the medial acid lateral caudate-putamen and the shell a
nd core of the nucleus accumbens following hypersensitization. No change in
CArG-binding protein A expression level was found in the dopamine-depleted
, drug naive animals relative to controls. Regions of the basal ganglia whe
re increases in CArG-binding protein A were detected following each treatme
nt correlated perfectly with c-Fos protein induction.
The results demonstrate that CArG-binding protein A responds to SKF-82958 a
nd that the changes in CArG-binding protein A match perfectly with the patt
ern of c-Fos induction induced by the D1 agonist. (C) 2000 IBRO. Published
by Elsevier Science Ltd. All rights reserved.